Chairman Helge Lund (pictured) and six other directors are stepping down from the company following a dispute with its ...

Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to ...

There's growing interest among women to take GLP-1 drugs like semaglutide for weight loss after giving birth and while ...

Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

After clearing Novo Nordisk’s semaglutide treatments Ozempic and Wegovy to reduce the risk of major adverse cardiovascular ...

Denmark's Novo Nordisk said Tuesday it would replace more than half of its board, including the chair, as the Ozempic and ...

Novo Nordisk A/S Chairman Helge Lund is stepping down after a boardroom dispute over governance and will be replaced by Lars Rebien Sorensen, a previous leader of the company who now heads its biggest ...

An April 2025 report from the Initiative for Medicines, Access & Knowledge (I-MAK) presents grossly misleading information ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

A new interactive budget tool from Levity helps users see whether GLP-1 medications fit into their real-world finances.

Clinical Director of the National Institute of Drug Abuse Dr. Lorenzo Leggio, said GLP-1 drugs' effect on the brain can help ...